Please login to the form below

Not currently logged in
Email:
Password:

Flulaval Quadrivalent

This page shows the latest Flulaval Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

China weighs heavy on GSK figures in Q3

China weighs heavy on GSK figures in Q3

Witty emphasised that GSK is entering a new product launch phase with four approvals since the start of the year - including quadrivalent flu vaccine FluLaval and Tyverb (lapatinib) for use alongside

Latest news

  • GSK gets OK for second quadrivalent flu vaccine in US GSK gets OK for second quadrivalent flu vaccine in US

    GSK gets OK for second quadrivalent flu vaccine in US. FDA approves Flulaval Quadrivalent. ... The latest approval is for Flulaval Quadrivalent, which has been given the OK by the FDA for use in patients aged three years or over to protect against A and

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics